Clinical Trial Update: Clinical Observation of CABA System in the Treatment of End-stage Liver Disease With Inflammation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the clinical efficacy and safety of the new ALSS (CABA System) for end-stage liver disease with inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• ALSS
• CABA System

Snippet

Sponsor: Qin Ning | Conditions: To Evaluate the Clinical Efficacy and Safety of the New ALSS | Phase 4 | Status: UNKNOWN